查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553661

质子束治疗系统市场规模、份额、趋势分析报告：按产品、类型、地区和细分市场预测，2024-2030

Proton Therapy Systems Market Size, Share & Trends Analysis Report By Product (Equipment, Services), By Type (Single-Room System, Multi-Room System), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

质子治疗系统市场成长与趋势

Grand View Research, Inc.的研究报告显示，预计2024年至2030年全球质子治疗系统市场规模将以7.3%的复合年增长率成长，2030年将达到12亿美元。

这个市场主要由质子治疗中心的增加、癌症病例的增加以及医院设立中心的投资增加所推动。

医院、製造商和私人投资者不断增加的资金和投资也促进了该市场的成长。例如，2015年8月，Mevion Medical Systems（美国）获得由厚朴投资（中国）和元明资本（中国）主导的2亿美元股权融资。这些资金很可能用于开发技术先进且低成本的产品。此外，各地区政府都已列入建立此类中心的预算。例如，2015年7月，维多利亚州政府拨款约200万澳元（153万美元）在维多利亚综合癌症中心（VCCC）建立国家质子治疗中心。

此外，全球癌症患者数量的快速增加预计将推动预测期内的市场成长。据美国癌症协会称，2017 年美国将诊断出 1,688,780 例新癌症病例，约 600,920 人将死于该疾病。此外，根据《刺胳针》报道，到 2030 年，被诊断出乳房肿瘤的女性人数预计将达到 320 万人，几乎是 2015 年 170 万人的两倍。

美国和欧洲国家有利的报销政策以及新兴国家癌症相关医疗费用的增加可能会推动全球质子治疗系统市场的发展。此外，成本下降、认识提高和质子治疗采用率的提高预计将在预测期内推动对这些系统的需求。然而，建立这些中心的高成本以及新兴国家缺乏报销可能会限制未来几年的成长。

质子治疗系统市场报告亮点

  • 由于建立质子治疗中心的合约数量增加，设备部门占据了2023年大部分收益占有率。
  • 多房间系统在 2030 年占据最大的市场收益占有率，达到 67.4%。
  • 2023年北美质子治疗系统市场占42.7%的市场占有率。
  • 预计亚太质子治疗系统市场在预测期内复合年增长率最快。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章质子束治疗系统市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 质子束治疗系统市场分析工具
    • 波特的分析
    • PESTEL分析

第四章质子束治疗系统市场：依产品估计和趋势分析

  • 细分仪表板
  • 质子治疗系统市场：2023 年和 2030 年产品变化分析
  • 装置
  • 服务

第五章质子束治疗系统市场：按类型估计和趋势分析

  • 细分仪表板
  • 质子治疗系统市场：类型变化分析，2023 年和 2030 年
  • 单间系统
  • 多房间系统

第六章质子束治疗系统市场：区域、估计和趋势分析

  • 2023 年及 2030 年质子治疗系统市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Ion Beam Applications SA
    • Optivus Proton Therapy, Inc.
    • Mevion Medical Systems
    • Advanced Oncotherapy plc
    • Varian Medical Systems, Inc
    • ProTom International, Inc
    • Hitachi, Ltd.
    • Mitsubishi Corporation
    • ProNova Solutions, LLC
    • Sumitomo Heavy Industries, Ltd
简介目录
Product Code: GVR-1-68038-499-4

Proton Therapy Systems Market Growth & Trends:

The global proton therapy systems market size is expected to reach USD 1.2 billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030, according to a report by Grand View Research, Inc. The market is primarily driven by increasing number of proton therapy centers, rising number of cancer cases, and growing investments by hospitals to establish these centers.

Growing funds & investments by hospitals, manufacturers, and private investors are also contributing to the growth of this market. For instance, in August 2015, Mevion Medical Systems (U.S.) raised USD 200 million in an equity funding led by HOPU Investments (China) and YuanMing Capital (China). These funds are likely to be used for development of technologically advanced and low-cost products. Furthermore, governments across various geographies are including budgets for establishment of these centers. For instance, in July 2015, the state government of Victoria included nearly AUD 2 million (USD 1.53 million) to develop a National Centre for Proton Beam Therapy at the Victorian Comprehensive Cancer Centre (VCCC). The new center is expected to offer treatment to the patients in Australia.

In addition, rapid increase in the number of cancer cases globally is anticipated to bolster market growth during the forecast period. According to American Cancer Society, an estimated 1,688,780 new cancer cases are expected to be diagnosed in the U.S. and this disorder is likely to cause nearly 600,920 deaths in 2017. Furthermore, according to The Lancet, the number of women diagnosed with breast tumors is estimated to reach 3.2 million by 2030, which is almost double of 1.7 million in 2015.

Favorable reimbursement policies in the U.S and European countries and rising cancer-related healthcare expenditure in emerging nations is likely to propel the global proton therapy systems market. In addition, decreasing cost of proton therapy, increasing awareness, and rising adoption are expected to boost demand for these systems during the forecast period. However, high costs involved in the establishment of these centers and lack of reimbursement in emerging nations is likely to restrain growth in the coming years.

Proton Therapy Systems Market Report Highlights:

  • The equipment segment held majority of the revenue share in 2023 due to rise in the number of contracts for establishment of proton therapy centers
  • The multi-room systems accounted for the largest market revenue share of 67.4% in 2030
  • North America proton therapy systems market dominated in 2023 and accounted for the market share of 42.7%.
  • Asia Pacific proton therapy systems market is estimated to register the fastest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Proton Therapy Systems Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Proton Therapy Systems Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Proton Therapy Systems Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Proton Therapy Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Proton Therapy Systems Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Proton Therapy Systems Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Single-Room Systems
    • 5.3.1. Single-Room Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Multi-Room Systems
    • 5.4.1. Multi-Room Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Proton Therapy Systems Market: Regional Estimates & Trend Analysis

  • 6.1. Proton Therapy Systems Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Ion Beam Applications S.A.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Optivus Proton Therapy, Inc.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Mevion Medical Systems
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Advanced Oncotherapy plc
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Varian Medical Systems, Inc
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. ProTom International, Inc
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Hitachi, Ltd.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Mitsubishi Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. ProNova Solutions, LLC
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Sumitomo Heavy Industries, Ltd
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives